HCPCS Level II
J0712
Injection, ceftaroline fosamil, 10 mg
Codes near J0712
These sit next to J0712 in the CMS Level II file. All J codes
- J0701Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
- J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
- J0703Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
- J0706Injection, caffeine citrate, 5 mg
- J0710Injection, cephapirin sodium, up to 1 gm
- J0713Injection, ceftazidime, per 500 mg
- J0714Injection, ceftazidime and avibactam, 0.5 g/0.125 g
- J0715Injection, ceftizoxime sodium, per 500 mg
- J0716Injection, centruroides immune f(ab)2, up to 120 milligrams
- J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00456-0400-10 | Teflaro | Allergan, Inc. | 400 |
| 00456-0600-10 | Teflaro | Allergan, Inc. | 600 |
| 60505-6124-01 | Ceftaroline Fosamil | Apotex Corp. | 400 |
| 60505-6125-01 | Ceftaroline Fosamil | Apotex Corp. | 600 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.